McEnany Patrick J's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Aug 19, 2022
- Accession no.
- 0001161697-22-000399
- Filed
- Aug 19, 2022
- Trade date
- Aug 18-19, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $4.20M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McEnany Patrick JCIK 0000929985 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +25,000 | $2.53 | +$63,250 | 4,955,217 | Direct | |
| Aug 18, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −25,000 | $13.93F1,F6 | −$348,250 | 4,930,217 | Direct | |
| Aug 18, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +50,000 | $2.53 | +$126,500 | 4,980,217 | Direct | |
| Aug 18, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −50,000 | $13.93F2,F6 | −$696,500 | 4,930,217 | Direct | |
| Aug 18, 2022 | Common Stock, par value $0.001 per share | MOption exerciseAcquired | +50,000 | $2.53 | +$126,500 | 4,980,217 | Direct | |
| Aug 18, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −50,000 | $13.96F3,F6 | −$698,000 | 4,930,217 | Direct | |
| Aug 18, 2022 | Common stock,. par value $0.001 per share | MOption exerciseAcquired | +50,000 | $2.53 | +$126,500 | 4,980,217 | Direct | |
| Aug 18, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −50,000 | $13.95F4,F6 | −$697,500 | 4,930,217 | Direct | |
| Aug 19, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +125,000 | $2.53 | +$316,250 | 5,055,217 | Direct | |
| Aug 19, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −125,000 | $14.10F5,F6 | −$1,762,500 | 4,930,217 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 3,640,834 | Direct | |
| Aug 18, 2022 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 3,590,834 | Direct | |
| Aug 18, 2022 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 3,540,834 | Direct | |
| Aug 18, 2022 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 3,490,834 | Direct | |
| Aug 19, 2022 | Common Stock | MOption exerciseDisposed | −125,000 | $0.00 | $0 | 3,365,834 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares were sold in various lots from $13.93 to $13.97 per share. The listed sales price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.
- F2
Shares were sold in various lots from $13.93 to $13.94 per share. The listed sales price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.
- F3
Shares were sold in various lots from $13.95 to $14.00 per share. The listed sales price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.
- F4
Shares were sold in various lots from $13.95 to $13.98 per share. The listed sales price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.
- F5
Shares were sold in various lots from $14.05 to $14.14 per share. The listed sales price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.
- F6
Shares were sold to cover the exercise price of options, tax withholding requirements (if applicable) and for personal reasons. The shares were not sold as a result of any agreement with the Company and Mr. McEnany remains an officer of the company.
Referenced by the price of 5 transactions in Table I.